BioCatalystWatch
IOVAWorkspace / IOVA / OverviewCompany library
IOVANCE BIOTHERAPEUTICS, INC. logo

IOVANCE BIOTHERAPEUTICS, INC.

IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Website

Price
Market cap
Next catalystPOSITILITY enrollment beginning November 2026Lifileucel — POSITILITY, IOV-LUN-202 Cohort 5 · Trial initiationSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

Amtagvi (lifileucel)

PreINDP1P2P3FilingApproved
Upcoming / outlook

Amtagvi (lifileucel)

Upcoming / outlook

  • Timing and evidence

Amtagvi (lifileucel)

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

IOV-5001

IL-12R

PreINDP1P2P3FilingApproved
Amtagvi (lifileucel)Lifileucel — POSITILITY, IOV-LUN-202 Cohort 5

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Amtagvi (lifileucel)

PreINDP1P2FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Amtagvi (lifileucel)

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Amtagvi (lifileucel)Lifileucel — POSITILITY, IOV-LUN-202 Cohort 5

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Amtagvi (lifileucel)

PreINDP1P2FilingApproved
Upcoming / outlook

Amtagvi (lifileucel)

Upcoming / outlook

  • Timing and evidence

Amtagvi (lifileucel)

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

IOV-3001

IL-2R

PreINDP1P2P3FilingApproved
Amtagvi (lifileucel)

PreINDP1P2P3FilingApproved
IOV-4001

PD-1

PreINDP1P2P3FilingApproved
IOV-4001

PD-1

PreINDP1P2P3FilingApproved

Approved / commercial

Amtagvi (lifileucel)

PreINDP1P2P3FilingApproved
Upcoming / outlook

History / paused

Amtagvi (lifileucel)

PreINDP1P2P3FilingApproved
Amtagvi (lifileucel)

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Operating
Investing
Financing

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

IOVA PR & News

PR & News

IOVA SEC archive